DP-QB-MYA-002

AXP000241.1 · Phage therapy

Platform
phage cocktail (non-engineered)
Sponsor
Alberta Health Services

Names

NameTypeSource
DP-QB-MYA-002preferred name, codecurator, ctgov

Virus

Role
Phage
Family
Caudoviricetes
Virus
Mycobacterium abscessus bacteriophage (cocktail)
Replication
replicating
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07429162Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary InfectionNot yet recruitingPhase 12026-07-022027-07-021Bacteriophage Therapy; Mycobacterium Abscessus Infection; Pulmonary Disease

Recent changes

No changes recorded in its trials yet.

Notes

Phage cocktail against Mycobacterium abscessus subsp. abscessus pulmonary infection; phase 1 NCT07429162. Manufacturer not taken from a primary source.

How to cite

DP-QB-MYA-002 (AXP000241.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000241.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.